Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Victor Fuchs is active.

Publication


Featured researches published by Victor Fuchs.


Tetrahedron | 1993

The efficient synthesis and simple resolution of a prolineboronate ester suitable for enzyme-inhibition studies

Terence A. Kelly; Victor Fuchs; Clark Perry; Roger J. Snow

Abstract A method for the preparation and resolution of the pinanediol ester of prolineboronic acid is described. The method takes advantage of the ease of both the lithiation and the reduction of boc-pyrrole to generate the desired compound rapidly and in high yield.


Journal of Organic Chemistry | 2013

Zinc Catalyzed and Mediated Asymmetric Propargylation of Trifluoromethyl Ketones with a Propargyl Boronate

Daniel R. Fandrick; Jonathan T. Reeves; Johanna M. Bakonyi; Prasanth R. Nyalapatla; Zhulin Tan; Oliver Niemeier; Deniz Akalay; Keith R. Fandrick; Wolfgang Wohlleben; Swetlana Ollenberger; Jinhua J. Song; Xiufeng Sun; Bo Qu; Nizar Haddad; Sanjit Sanyal; Sherry Shen; Shengli Ma; Denis Byrne; Ashish Chitroda; Victor Fuchs; Bikshandarkoil Narayanan; Nelu Grinberg; Heewon Lee; Nathan K. Yee; Michael Brenner; Chris H. Senanayake

The development of zinc-mediated and -catalyzed asymmetric propargylations of trifluoromethyl ketones with a propargyl borolane and the N-isopropyl-l-proline ligand is presented. The methodology provided moderate to high stereoselectivity and was successfully applied on a multikilogram scale for the synthesis of the Glucocorticoid agonist BI 653048. A mechanism for the boron-zinc exchange with a propargyl borolane is proposed and supported by modeling at the density functional level of theory. A water acceleration effect on the zinc-catalyzed propargylation was discovered, which enabled a catalytic process to be achieved. Reaction progress analysis supports a predominately rate limiting exchange for the zinc-catalyzed propargylation. A catalytic amount of water is proposed to generate an intermediate that catalyzes the exchange, thereby facilitating the reaction with trifluoromethyl ketones.


Journal of Organic Chemistry | 2013

Development of a large scale asymmetric synthesis of the glucocorticoid agonist BI 653048 BS H3PO4.

Jonathan T. Reeves; Daniel R. Fandrick; Zhulin Tan; Jinhua J. Song; Sonia Rodriguez; Bo Qu; Soojin Kim; Oliver Niemeier; Zhibin Li; Denis Byrne; Scot Campbell; Ashish Chitroda; Phil DeCroos; Thomas Fachinger; Victor Fuchs; Nina C. Gonnella; Nelu Grinberg; Nizar Haddad; Burkhard Jäger; Heewon Lee; Jon C. Lorenz; Shengli Ma; Bikshandarkoil Narayanan; Larry J. Nummy; Ajith Premasiri; Frank Roschangar; Max Sarvestani; Sherry Shen; Earl Spinelli; Xiufeng Sun

The development of a large scale synthesis of the glucocorticoid agonist BI 653048 BS H3PO4 (1·H3PO4) is presented. A key trifluoromethyl ketone intermediate 22 containing an N-(4-methoxyphenyl)ethyl amide was prepared by an enolization/bromine-magnesium exchange/electrophile trapping reaction. A nonselective propargylation of trifluoromethyl ketone 22 gave the desired diastereomer in 32% yield and with dr = 98:2 from a 1:1 diastereomeric mixture after crystallization. Subsequently, an asymmetric propargylation was developed which provided the desired diastereomer in 4:1 diastereoselectivity and 75% yield with dr = 99:1 after crystallization. The azaindole moiety was efficiently installed by a one-pot cross coupling/indolization reaction. An efficient deprotection of the 4-methoxyphenethyl group was developed using H3PO4/anisole to produce the anisole solvate of the API in high yield and purity. The final form, a phosphoric acid cocrystal, was produced in high yield and purity and with consistent control of particle size.


Bioorganic & Medicinal Chemistry Letters | 1991

Imidazo[1,2-a]piperazines as mechanistic inhibitors of serine proteinases

Jerry W. Skiles; Victor Fuchs; Scott F. Leonard

Abstract The synthesis of imidazo[1,2-a]piperazines bearing a trifluoromethyl substituent, potential inhibitors of serine proteinases, is illustrated.


Journal of Medicinal Chemistry | 1991

Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones.

Karl D. Hargrave; John R. Proudfoot; Karl G. Grozinger; Ernest Cullen; Suresh R. Kapadia; Usha R. Patel; Victor Fuchs; Scott C. Mauldin; Jana Vitous; Mark L. Behnke; Janice M. Klunder; Kollol Pal; Jerry W. Skiles; Daniel W. McNeil; Janice M. Rose; Grace C. Chow; Mark T. Skoog; Joe C. Wu; Gunther Schmidt; Wolfhard Engel; Wolfgang Eberlein; Tracy D. Saboe; Scot Campbell; Alan S. Rosenthal; Julian Adams


Journal of Organic Chemistry | 2006

Efficient Large-Scale Synthesis of BILN 2061, a Potent HCV Protease Inhibitor, by a Convergent Approach Based on Ring-Closing Metathesis

Nathan K. Yee; Vittorio Farina; Ioannis N. Houpis; Nizar Haddad; Rogelio P. Frutos; Fabrice Gallou; Xiao-Jun Wang; Xudong Wei; Robert D. Simpson; XuWu Feng; Victor Fuchs; Yibo Xu; Jonathan Tan; Li Zhang; Jinghua Xu; Lana L. Smith-Keenan; Jana Vitous; Michael D. Ridges; and Earl M. Spinelli; Michael E. Johnson; Kai Donsbach; Thomas Nicola; Michael Brenner; Eric Winter; and Paul Kreye; Wendelin Samstag


Synthesis | 2006

Practical synthesis of 2-(2-isopropylaminothiazol-4-yl)-7-methoxy-1H-quinolin-4-one : Key intermediate for the synthesis of potent HCV NS3 protease inhibitor BILN 2061

Rogelio P. Frutos; Nizar Haddad; Ioannis N. Houpis; Michael E. Johnson; Lana L. Smith-Keenan; Victor Fuchs; Nathan K. Yee; Vittorio Farina; Anne-Marie Faucher; Christian Brochu; Bruno Haché; Jean-Simon Duceppe; Pierre L. Beaulieu


Journal of Heterocyclic Chemistry | 1995

Synthesis of nevirapine and its major metabolite

Karl G. Grozinger; Victor Fuchs; Karl D. Hargrave; S. Mauldin; Jana Vitous; Scot Campbell; Julian Adams


Archive | 1981

Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones

Kurt Freter; Victor Fuchs; James T. Oliver


Journal of Organic Chemistry | 1983

Fischer indole synthesis from cis- and trans-hexahydro-7-methyl-6-isoquinolones. Proton NMR determination of the configuration and conformation of products

Kurt Freter; Victor Fuchs; T. Phil Pitner

Collaboration


Dive into the Victor Fuchs's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bo Qu

Boehringer Ingelheim

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge